CVS CEO sees bonus reduced due to opioid settlement


Karen Lynch was not CEO during the years CVS was accused of helping to fuel the nation's opioid crisis but took a $1.5 million reduction in her non-equity incentive pay for 2022.

Previous Healey says abortion medication will remain protected in Mass., orders pills to be stockpiled
Next Availity picks up business unit from health tech AI unicorn